A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
Clinical trial NCT00799539 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT00799539
- Sponsor
- Janssen-Ortho Inc., Canada
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.